Latest Insider Transactions at Rockwell Medical, Inc. (RMTI)
This section provides a real-time view of insider transactions for Rockwell Medical, Inc. (RMTI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ROCKWELL MEDICAL, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ROCKWELL MEDICAL, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 17
2023
|
Marc L Hoffman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,665
+50.0%
|
-
|
Mar 17
2023
|
Paul E Mc Garry SVP, Finance and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
28,515
+50.0%
|
-
|
Jun 07
2022
|
Allen Nissenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+20.08%
|
-
|
Jun 07
2022
|
Andrea Heslin Smiley Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+21.08%
|
-
|
Jun 07
2022
|
John G Cooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+16.04%
|
-
|
Jun 07
2022
|
Mark H Ravich Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+8.23%
|
-
|
Jun 07
2022
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+18.56%
|
-
|
Jun 17
2021
|
Allen Nissenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+40.16%
|
-
|
Jun 17
2021
|
John Peter Mclaughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.74%
|
-
|
Jun 17
2021
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+37.12%
|
-
|
Jun 17
2021
|
Andrea Heslin Smiley Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+42.16%
|
-
|
Jun 17
2021
|
John G Cooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+32.08%
|
-
|
Jun 17
2021
|
Mark H Ravich Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+16.47%
|
-
|
Dec 21
2020
|
David S. Richmond > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
42,450
-2.88%
|
$42,450
$1.03 P/Share
|
Dec 16
2020
|
David S. Richmond > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
521,876
-34.05%
|
$521,876
$1.02 P/Share
|
Dec 15
2020
|
David S. Richmond > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
278,124
-4.34%
|
$278,124
$1.11 P/Share
|
Dec 11
2020
|
Allen Nissenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,488
+5.73%
|
-
|
Dec 11
2020
|
Andrea Heslin Smiley Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,601
+50.0%
|
$18,601
$1.12 P/Share
|
Dec 07
2020
|
Mark H Ravich Director |
BUY
Other acquisition or disposition
|
Indirect |
219,905
+50.0%
|
$219,905
$1.22 P/Share
|
Dec 07
2020
|
Mark H Ravich Director |
SELL
Other acquisition or disposition
|
Indirect |
219,905
-100.0%
|
$219,905
$1.22 P/Share
|
Jun 30
2020
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
19,813
+13.28%
|
$19,813
$1.93 P/Share
|
Jun 30
2020
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,868
+1.31%
|
$4,868
$1.95 P/Share
|
Aug 02
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
97
+0.18%
|
$194
$2.42 P/Share
|
Jul 31
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,807
+3.31%
|
$3,614
$2.66 P/Share
|
Jul 29
2019
|
Richmond Brothers, Inc. |
SELL
Open market or private sale
|
Direct |
179
-0.11%
|
$537
$3.12 P/Share
|
Jul 25
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
319
+0.08%
|
$957
$3.06 P/Share
|
Jul 24
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,579
+4.82%
|
$7,737
$3.13 P/Share
|
Jul 22
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
92,707
+36.48%
|
$185,414
$2.99 P/Share
|
Jul 19
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
68,750
+50.0%
|
$137,500
$2.89 P/Share
|
Jul 08
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,177
+3.0%
|
$27,531
$3.05 P/Share
|
Jul 08
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
603
+0.34%
|
$1,809
$3.05 P/Share
|
May 09
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,137
+1.38%
|
$20,685
$5.65 P/Share
|
May 09
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
506
+0.28%
|
$2,530
$5.65 P/Share
|
Mar 27
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,554
+0.87%
|
$7,770
$5.59 P/Share
|
Mar 27
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,315
+1.4%
|
$21,575
$5.59 P/Share
|
Oct 15
2018
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,541,562
+50.0%
|
-
|
Jun 28
2018
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,940
+3.78%
|
$31,760
$4.37 P/Share
|
Jun 27
2018
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,621
+11.84%
|
$18,484
$4.73 P/Share
|
Dec 15
2017
|
David S. Richmond > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
36
-0.02%
|
$216
$6.53 P/Share
|
Aug 10
2017
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
605
+0.29%
|
$3,630
$6.34 P/Share
|